Ontology highlight
ABSTRACT: Background
Transcatheter aortic valve replacement (TAVR), widely used as an alternative therapy in patients with severe aortic stenosis, is expected to be offered to low-risk patents with a longer life expectancy. The durability of transcatheter aortic valve is becoming of increasing importance.Method
PubMed, Embase, and Cochrane CENTRAL from the inception to March 2020 were systematically screened for studies reporting on structural valve deterioration (SVD) in TAVR patients. Incidence of SVD was diagnosed according to the latest European consensus as the primary end point. Predictors of SVD evaluated at multivariable analysis and cumulative incidence function (CIF) of SVD were the secondary end point.Result
Twelve studies encompassing 10031 patients evaluating the
SUBMITTER: Long YX
PROVIDER: S-EPMC7657687 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature